News
News from us and our partners
Tags
Topics
0 results
- News
Comet Biorefining to build first commercial cellulosic sugar plant
- News
Sofinnova Partners leads Enyo Pharma €22M financing
- News
Mission Therapeutics raises £60 million to progress
- News
Bioamber Inc. announces pricing of $13.0 million public offering
- News
Sofinnova Partners raises €300 million healthcare fund
- News
Additional Data Confirm Positive Results for Clinical Trial of ReActiv8®
- News
TWB announces the creation of EnobraQ, specialist in CO2 capture and exploitation using yeast
- News
Lysogene Receives Orphan Drug Designation and Rare Pediatric Disease Designation from the FDA
- News
ObsEva Closes CHF 60 (USD 60) Million in Series B Financing
- News
Crescendo Biologics Appoints Dr Kevin Johnson as Chairman
- News
Sofinnova launches BiovelocITA: the first biotech accelerator in Italy
- News
TWB announces the creation of EnobraQ, specialist in CO2 capture and exploitation using yeast
- News
Mainstay Medical Applies for CE Mark for ReActiv8®
- News
Mainstay Medical Applies for CE Mark for ReActiv8®
- News
RefleXion Medical Achieves Major Milestones in Development of Biologically-Guided Radiotherapy